Position in KROS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,861,821
-$2,764,251 QoQ
Shares Held
267,460
-47.5% QoQ
Ownership
1.35%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#17
of 131 holders
Holding Since
Dec 2020
14 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in KROS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026D. E. Shaw & Co., Inc. holds $5,017,559,982 across 217 Biotechnology names. KROS ranks #117 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
5,877,959 | $626,707,987 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,104,109 | $332,369,932 | |
| 3 | EXEL |
Exelixis, Inc.
|
5,551,747 | $302,070,554 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
3,633,007 | $270,586,360 | |
| 5 | TGTX |
Tg Therapeutics, Inc.
|
3,400,808 | $186,840,390 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
2,006,479 | $157,047,110 | |
| 7 | AXSM |
Axsome Therapeutics, Inc.
|
604,753 | $148,025,391 | |
| 8 | PTCT |
Ptc Therapeutics, Inc.
|
1,548,919 | $126,345,322 |
All Filings in KROS
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,861,821 | 267,460 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $5,626,072 | 509,608 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $15,381,430 | 755,473 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $21,063,143 | 1,331,425 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $17,320,063 | 1,297,383 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $12,871,294 | 1,263,130 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $191,527 | 12,099 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $10,817,744 | 186,288 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $8,029,261 | 175,695 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,249,458 | 18,874 | Shares | Defined | 2024-05-15 | |
| 2023-03-31 | $1,325,066 | 31,032 | Shares | Defined | 2023-05-15 | |
| 2022-06-30 | $581,777 | 21,056 | Shares | Defined | 2022-08-15 | |
| 2021-03-31 | $1,609,040 | 26,142 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $3,893,949 | 55,202 | Shares | Defined | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||